PAUL CALABRESI, M.D.; OVID O. MEYER, M.D., F.A.C.P.
The successful use of radioactive phosphorus for the treatment of polycythemia vera was first reported by Lawrence9 in 1940. By 1946 there was substantial agreement that this was the treatment of choice for this condition.13, 14 Since that time the general availability of this isotope to larger medical centers has allowed the study of appreciable numbers of cases by single clinics. From this opportunity a better understanding of the course and complications of this disease process has come forth. The physical and biologic characteristics of P32, as well as the rationale for its use in polycythemia vera, have been well
CALABRESI P, MEYER OO. POLYCYTHEMIA VERA. II. COURSE AND THERAPY1. Ann Intern Med. ;50:1203–1216. doi: 10.7326/0003-4819-50-5-1203
Download citation file:
Published: Ann Intern Med. 1959;50(5):1203-1216.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use